Fluidized Bed:
The basic principle behind a fluidized-bed combustor is the distribution of the air homogeneously across a combustion area where the bed of the
fuel and inert mineral particles are fluidized, that is, the air velocity achieves the mass suspension of the bed particles. This is made possible by blowing the air at relatively high pressures (around 0.15 bar concerning grate firing in which five times lower pressures are considered) through a distribution plate on top of which the bed of
fuel and inert is positioned. A fluidized-bed burner, therefore, is a high cylindrical or square sectioned vessel that rests on the bottom part of a perforated plate, positioned to separate the furnace from a pressurized air-box. The inert material represents up to 98% of the bed material. It acts as a grate because it supports the
fuel which floats in it and causes the abrasion of the
fuel particles. It also acts as a refractor by radiating heat and providing conduction due to the continuous turbulent collisions with
fuel particles. The high
turbulence optimizes combustion and hence, low excess air is required (from 10% to 30%). The mixing effect can be used to reduce emissions that are formed by injecting reactants such as urea for NOx control and limestone for reducing acid gases, directly into the bed.
High Impact List of Articles
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Pooling of lupus can "catch" early skin cancerous: "Rapid Progression in DNA Damage"
Rahul Hajare
Commentary: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
Review Article: Clinical Investigation
-
The rationale and evidence for triple antiplatelet therapy in acute coronary syndromes
Beau M Hawkins, Jorge F Saucedo, Sunil V Rao
Review Article: Clinical Investigation
-
Developing an international network for clinical research: the European and Developing Countries Clinical Trials Partnership experience
Charles Mgone, Michael Makanga, Thomas Nyirenda
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the European and Developing Countries Clinical Trials Partnership experience
Charles Mgone, Michael Makanga, Thomas Nyirenda
Clinical Trail Outcomes: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
Relevant Topics in Clinical